Rongchang Biopharma Unlocks 193 Million Restricted Shares on July 1

According to its official announcement, Rongchang Biopharma (09995) will unlock 193 million restricted shares for trading on July 1, 2026. The shares, part of the company's initial public offering restricted stock, will be listed on the Shanghai Stock Exchange. However, due to insufficient cash dividends, shareholders seeking to unlock these shares are currently prohibited from reducing their holdings through centralized trading or block trades.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments